{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:38:47Z","timestamp":1793500727433,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaccao.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:23:37Z","timestamp":1765826617000},"page":"870-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pretreatment Circulating Vascular Biomarkers Predict Cancer Therapy\u2013Related Cardiac Dysfunction During HER2+ Breast Cancer Treatment"],"prefix":"10.1016","volume":"7","author":[{"given":"Dakota","family":"Gustafson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crizza","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbar","family":"Nardi-Agmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1025-5480","authenticated-orcid":false,"given":"Christopher","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Po","family":"Steve Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Houbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-0899","authenticated-orcid":false,"given":"Thomas","family":"Marwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Abdel-Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1371-1250","authenticated-orcid":false,"given":"Chris","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paaladinesh","family":"Thavendiranathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2025.09.004_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamacardio.2016.3841","article-title":"A population-based study of cardiovascular mortality following early-stage breast cancer","volume":"2","author":"Abdel-Qadir","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib2","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1200\/JCO.2015.65.1505","article-title":"Breast cancer therapy-related cardiac dysfunction in adult women treated in routine clinical practice: a population-based cohort study","volume":"34","author":"Thavendiranathan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100461","article-title":"Anthracyclines in the treatment of patients with early breast cancer","volume":"7","author":"Guarneri","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.jaccao.2025.09.004_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1139\/cjpp-2023-0358","article-title":"Preventing broken hearts in women with breast cancer: a concise review on chemotherapy-mediated cardiotoxicity","volume":"102","author":"Bews","year":"2024","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/annonc\/mdf170","article-title":"Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy","volume":"13","author":"Cardinale","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014708","article-title":"Changes in cardiovascular biomarkers with breast cancer therapy and associations with cardiac dysfunction","volume":"9","author":"Demissei","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2025.09.004_bib7","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"Fallah-Rad","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jacc.2013.10.061","article-title":"Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab","volume":"63","author":"Ky","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.029574","article-title":"Circulating cardiovascular biomarkers in cancer therapeutics-related cardiotoxicity: review of critical challenges, solutions, and future directions","volume":"12","author":"Murtagh","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2025.09.004_bib10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1042\/CS20210059","article-title":"Cancer therapy-related cardiac dysfunction: is endothelial dysfunction at the heart of the matter?","volume":"135","author":"Ching","year":"2021","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jaccao.2025.09.004_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacbts.2018.06.005","article-title":"Role of endothelium in doxorubicin-induced cardiomyopathy","volume":"3","author":"Luu","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jaccao.2025.09.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108116","article-title":"Endothelial dysfunction as a complication of anti-cancer therapy","volume":"237","author":"Terwoord","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaccao.2025.09.004_bib13","first-page":"2933","article-title":"Biomarkers of inflammation, hypercoagulability and endothelial injury predict early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patients","volume":"10","author":"Todorova","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jaccao.2025.09.004_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cvr\/cvab053","article-title":"Coronary microcirculation damage in anthracycline cardiotoxicity","volume":"118","author":"Galan-Arriola","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2025.09.004_bib15","first-page":"15","article-title":"Damage to cardiac vasculature may be associated with breast cancer treatment-induced cardiotoxicity","volume":"7","author":"Hoffman","year":"2021","journal-title":"Cardiooncology"},{"key":"10.1016\/j.jaccao.2025.09.004_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149117","article-title":"Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism","volume":"132","author":"Szczepaniak","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaccao.2025.09.004_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacc.2017.05.019","article-title":"Arginine-nitric oxide metabolites and cardiac dysfunction in patients with breast cancer","volume":"70","author":"Finkelman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-012-2039-z","article-title":"High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study","volume":"134","author":"Onitilo","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaccao.2025.09.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacbts.2021.10.010","article-title":"Paraoxonase-1 activity in breast cancer patients treated with doxorubicin with or without trastuzumab","volume":"7","author":"Thompson","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jaccao.2025.09.004_bib20","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa2003608","article-title":"A novel circulating microRNA for the detection of acute myocarditis","volume":"384","author":"Blanco-Dominguez","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2025.09.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103982","article-title":"Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies","volume":"78","author":"Gustafson","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaccao.2025.09.004_bib22","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCRESAHA.117.311312","article-title":"Cardiovascular event prediction by machine learning: the Multi-Ethnic Study of Atherosclerosis","volume":"121","author":"Ambale-Venkatesh","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2025.09.004_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41746-022-00712-8","article-title":"Multimodal machine learning in precision health: a scoping review","volume":"5","author":"Kline","year":"2022","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.jaccao.2025.09.004_bib24","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jcmg.2020.09.039","article-title":"Serial cardiovascular magnetic resonance strain measurements to identify cardiotoxicity in breast cancer: comparison with echocardiography","volume":"14","author":"Houbois","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2025.09.004_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamacardio.2021.5881","article-title":"A combined echocardiography approach for the diagnosis of cancer therapy-related cardiac dysfunction in women with early-stage breast cancer","volume":"7","author":"Esmaeilzadeh","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ehjcvp\/pvad031","article-title":"Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines","volume":"9","author":"Thavendiranathan","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jaccao.2025.09.004_bib27","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jcmg.2018.03.019","article-title":"Rationale and design of the strain surveillance of chemotherapy for improving cardiovascular outcomes: the SUCCOUR trial","volume":"11","author":"Negishi","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2025.09.004_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","article-title":"Cancer therapy\u2013related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging","volume":"9","author":"Bloom","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jaccao.2025.09.004_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaccao.2025.09.004_bib31","doi-asserted-by":"crossref","first-page":"W460","DOI":"10.1093\/nar\/gkv403","article-title":"DIANA-miRPath v3.0: deciphering microRNA function with experimental support","volume":"43","author":"Vlachos","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaccao.2025.09.004_bib32","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017","journal-title":"Preprint"},{"key":"10.1016\/j.jaccao.2025.09.004_bib33","doi-asserted-by":"crossref","DOI":"10.4161\/cib.25849","article-title":"Comparison of normalization methods for differential gene expression analysis in RNA-seq experiments: a matter of relative size of studied transcriptomes","volume":"6","author":"Maza","year":"2013","journal-title":"Commun Integr Biol"},{"issue":"3","key":"10.1016\/j.jaccao.2025.09.004_bib34","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/cancers12030704","article-title":"MicroRNAs in cancer treatment-induced cardiotoxicity","volume":"12","author":"Pellegrini","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaccao.2025.09.004_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.2005.03.5956","article-title":"Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study","volume":"24","author":"Chow","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib36","doi-asserted-by":"crossref","first-page":"H705","DOI":"10.1152\/ajpheart.00370.2019","article-title":"Detrimental effects of chemotherapy on human coronary microvascular function","volume":"317","author":"Hader","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib37","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00756.2018","article-title":"Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer","volume":"317","author":"Sales","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643692","article-title":"Single-cell profiling to explore immunological heterogeneity of tumor microenvironment in breast cancer","volume":"12","author":"Yuan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib39","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jaccao.2025.09.004_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00395-023-01006-0","article-title":"Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy","volume":"118","author":"Nettersheim","year":"2023","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin\u2013Tie system","volume":"10","author":"Augustin","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijcard.2016.03.005","article-title":"Prognostic value of angiopoietin-2 in patients with chronic heart failure","volume":"212","author":"Eleuteri","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib43","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cardfail.2021.04.001","article-title":"Associations of angiopoietins with heart failure incidence and severity","volume":"27","author":"Peplinski","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jaccao.2025.09.004_bib44","doi-asserted-by":"crossref","first-page":"H959","DOI":"10.1152\/ajpheart.01251.2009","article-title":"The physiological role of endoglin in the cardiovascular system","volume":"299","author":"L\u00f3pez-Novoa","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib45","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.amjcard.2010.08.018","article-title":"Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure","volume":"106","author":"Kapur","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaccao.2025.09.004_bib46","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00380-011-0163-z","article-title":"Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases","volume":"27","author":"Ikemoto","year":"2012","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jaccao.2025.09.004_bib47","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1161\/CIRCULATIONAHA.111.080002","article-title":"Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure","volume":"125","author":"Kapur","year":"2012","journal-title":"Circulation"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087325003461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087325003461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T23:24:47Z","timestamp":1768605887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087325003461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2666087325003461"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2025.09.004","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment Circulating Vascular Biomarkers Predict Cancer Therapy\u2013Related Cardiac Dysfunction During HER2+ Breast Cancer Treatment","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}